Skip to Content
Blockchain

Coinbase is starting to look a lot like a traditional big tech company

July 17, 2018

The popular American cryptocurrency exchange is growing up fast—and becoming more like the kind of company that cryptocurrency was supposed to circumvent.

Two big news items: Coinbase has announced that it is “exploring the addition” of five new crypto-tokens—Cardano, the Basic Attention Token, Stellar Lumens, Zcash, and 0x—which would join Bitcoin, Litecoin, Ethereum, Bitcoin Cash, and Ethereum Classic. Just as important, Bloomberg reported yesterday that Coinbase has the “green light” from US securities regulators to make three acquisitions that will pave the way for it to become one of the first licensed platforms for trading “tokenized” versions of traditional investments, like company shares.

A contentious backdrop: Landing on a big exchange like Coinbase boosts a crypto-token’s perceived value, so a lot of money is on the line. But there are very few rules governing the process, and the debate over which coins the exchanges should be allowed to list is just beginning. Complicating things is a lack of clarity from regulators in the US and many other countries regarding which coins are commodities, which are securities, and which may be something different altogether.

This looks familiar: Coinbase, which may be worth as much as $8 billion, has been in rapid expansion mode lately. Some have called it a budding “Google of crypto.” But isn’t that antithetical to the decentralized ideal to which so many cryptocurrency enthusiasts adhere? Meet the new boss, same as the old boss.

Pictured above: Brian Armstrong, CEO of Coinbase

Keep Reading

Most Popular

The inside story of how ChatGPT was built from the people who made it

Exclusive conversations that take us behind the scenes of a cultural phenomenon.

How Rust went from a side project to the world’s most-loved programming language

For decades, coders wrote critical systems in C and C++. Now they turn to Rust.

Design thinking was supposed to fix the world. Where did it go wrong?

An approach that promised to democratize design may have done the opposite.

Sam Altman invested $180 million into a company trying to delay death

Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.